Trial NCT05167370

View at ClinicalTrials.gov 
Org. Study IDs: Amifostine

Last trial update was posted on 2022-01-25

MeSH Interventions

Amifostine

MeSH Conditions

Brain Neoplasms Neoplasms

Other Conditions

Brain Tumors Solid Tumors

Stopping Reasons

The study was terminated as recommended by the DSMB due to inability to meet enrollment goals within the time frame allotted (target of 25 patients over 5 years).

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID